Chugai Pharmaceutical Co., Ltd.

CUP.F·Frankfurt

Compare

36.36+0.61 (+1.71%)today

As of Oct 21, 3:25 PM CEST · May be delayed up to 15 min · EUR

Key statistics

Previous close35.75

Open36.44

Day range36.3236.44

52-week range33.5256.26

Off day high−0.22%

Off 52-week high−35.37%

Volume30.00

Avg. volume (3M)7.00

Market cap59.83B

EPS (TTM)1.59

Forward P/E0.25

P/E ratio (TTM)22.87

Dividend yield2.08% (0.7400)

Beta (5Y)—

Shares outstanding1.65B

Short interest—

Earnings dateOct 27, 2026

Analyst target—

Profit margin—

Against its peers

Compare in full ›

	CUP.F	4552.T	YPH.F	BIIB	1093.HK	002422.SZ
Market cap	59.83B	64.91B	24.92B	35.62B	99.23B	68.55B
P/E (TTM)	22.9	79.4	12.3	42.8	11.9	37.5
Forward P/E	0.2	14.5	—	14.6	13.0	28.7
Price/book	5.2	1.5	2.3	1.9	2.2	2.8
Dividend yield	2.08%	3.83%	3.28%	—	4.04%	1.38%
1-year change	−12.21%	−16.35%	+55.58%	+64.57%	+5.44%	+20.37%
Today	+1.71%	+1.92%	+1.46%	−0.84%	−2.47%	+0.05%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Chugai Pharmaceutical's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
JCR Pharmaceuticals Co., Ltd.4552.T · Drug Manufacturers - General	64.91B	532.00	+1.92%
Astellas Pharma Inc.YPH.F · Drug Manufacturers - General	24.92B	13.90	+1.46%
Biogen Inc.BIIB · Drug Manufacturers - General	35.62B	241.06	−0.84%
CSPC Pharmaceutical Group Limited1093.HK · Drug Manufacturers - General	99.23B	8.700	−2.47%
Sichuan Kelun Pharmaceutical Co., Ltd.002422.SZ · Drug Manufacturers - General	68.55B	43.09	+0.05%
Daiichi Sankyo Company, Limited4568.T · Drug Manufacturers - General	5.17T	2,841.00	+0.74%
Bristol-Myers Squibb CompanyBMY · Drug Manufacturers - General	124.53B	60.97	−1.16%
Recordati Industria Chimica e Farmaceutica S.p.A.REC.MI · Drug Manufacturers - General	11.01B	52.95	−0.09%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All CUP.F news ›

Defense World·Oct 7Positive

Analyzing Chugai Pharmaceutical (OTCMKTS:CHGCY) & Ascend Wellness (OTCMKTS:AAWH)

Posted by Defense World Staff on Oct 7th, 2026 Chugai Pharmaceutical (OTCMKTS:CHGCY – Get Free Report) and Ascend Wellness (OTCMKTS:AAWH – Get Free Report) are both healthcare companies, but which is the better business? We will compare…

From articles in the 4Search news index.

In the news

2mentions in 30 days

2with it in the headline

Positivesentiment

Most coverage from

defenseworld.net1
themarketsdaily.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

About

Profile ›

Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.

From Wikipedia, CC BY-SA 4.0

Earnings

Reported EPS
Estimate

Next report: Tue, Oct 27, 2026

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.